ArticleJournal of thrombosis and thrombolysis2015

Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis.

Carla Rognoni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.